2017 Publications

Book Chapter

  1. Hocking JS, Huston WM, Chen M. Chlamydia trachomatis Infection. In L Hinkle Bachmann (ed.), Sexually Transmitted Infections in HIV-Infected Adults and Special Populations: A Clinical Guide. 2017. Springer, pp. 51 - 69. doi: 10.1007/978-3-319-56694-8_3

Comments / Debates
  1. Jegaskanda S, Vanderven HA, Wheatley AK, Kent SJ. Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design. Human Vaccines and Immunotherapeutics 2017; 13(6): 1288-1296. doi: 10.1080/21645515.2017.1290018
  2. Kent SJ, Kelleher AD. Expanding role for Type I Interferons in restricting HIV growth. Immunology and Cell Biology 2017; 95: 417-18. doi: 10.1038/icb.2017.15
  3. Wilkinson AL, El-Hayek C, Fairley CK, Roth N, Tee BK, McBryde E, Hellard M & Stoové M. Wilkinson et al. Respond to “Latent transition analyses in clinical cohorts”. American Journal of Epidemiology 2017; 185(8): 639-640. doi: 10.1093/aje/kww238
  1. Zou H, Zhang L, Chow EPF, Tang W, Wang Z. Testing for HIV/STIs in China: Challenges, Opportunities, and Innovations. BioMed Research International 2017; 2545840: 1-3. doi: 10.1155/2017/2545840

  1. Chow EPF, Fairley CK. Could antiseptic mouthwash inhibit pharyngeal Neisseria gonorrhoeae? Further research is required. Sexually Transmitted Infection (Letter) 2017; 93(6): 403. doi:10.1136/sextrans-2017-053139
  2. Puhr R, Petoumenos K, Youds D, Law M, Templeton DJ, Ellis D, Bloch MS, Agrawal S, Vincent T, Allen D, Smith D, Rankin AC, Bake, D, O'Connor CC, Thackeray O, Jackson, E, McCallum K, Ryder N, Sweeney MG, Cooper D, Carr A, Macrae K, Hesse K, Finlayson GR, Gupta S, Langton-Lockton J, Shakeshaft J, Brown K, Idle S, Arvela N, Varma RP, Lu H, Couldwell D, Eswarappa,S, Smith DE, Furner V, Cabrera DG, Fernando S, Cogle A, Lawrence C, Mulhall BP, Boyd M, Law M, Huang R, Han A, Gunathilake M, Payne R, O'Sullivan M, Croydon A, Russell D, Cashman C, Roberts C, Sowden D, Taing K, Marshall P, Orth DN, Rowling D, Latch N, Warzywoda E, Dickson B, Donohue W, Moore R, Edwards S, Boyd S, Roth NJ, Lau H, Read T, Silvers J, Zeng W, Hoy J, Watson K, Bryant M, Price S, Woolley I, Giles M, Korman T, Williams J, Nolan D, Allen A, Guelfi G, Mills G, Wharry C, Raymond KN, Bargh K, the Australian HIV Observational Database (AHOD) study group. The impact of changes in HIV management guidelines on time to treatment initiation in Australia. HIV Medicine 2017; 18(9): 701-703. doi: 10.1111/hiv.12504

Review Articles

  1. Cornelisse VJ, Jones RA, Fairley CK, Grover SR.  The medical care of the neovagina of transgender women - a review. Sexual Health 2017; 14(5): 442-450.doi:10.1071/SH17044
  2. Fairley CK, Prestage G, Bernstein K, Mayer K, Gilbert M. 2020, sexually transmissible infections and HIV in gay bisexual and other men who have sex with men. Sexual Health 2017; 14(1): 1-4. doi:10.1071/SH16220
  3. Fairley CK, Zou H, Zhang L, Chow EPF. Human papillomavirus vaccination in men who have sex with men - What will be required by 2020 for the same dramatic changes seen in heterosexuals. Sexual Health 2017;14(1): 123-125.doi:10.1071/SH16067
  4. Juno JA, Bockel DV, Kent SJ, Kelleher AD, Zaunders JJ, Munier CML. Cytotoxic CD4 T cells-friend or foe during viral infection? Frontiers in Immunology 2017; 8: 19. doi: 10.3389/fimmu.2017.00019
  5. Vanderven HA, Jegaskanda S, Wheatley AK, Kent SJ. Antibody dependent cellular cytotoxicity and influenza virus. Current Opinion in Virology 2017; 22: 89-96. doi: 10.1016/j.coviro.2016.12.002
  6. Wines BD, Billings H, Mclean MR, Kent SJ, Hogarth PM. HIV-specific ADCC - new technologies to study ADCC and importance for the HIV vaccine field. Current HIV Research 2017; 15(3): 202-215. doi: 10.2174/1570162X15666170320112247

Journal Articles

  1. Ali H, McManus H, O'Connor C,  Callander D, Kong M, Graham S, Saulo D, Fairley CK, Regan D, Gruclich A, Low N, Guy R, Donovan B. Human papillomavirus vaccination associated with marked declines in genital warts among young Aboriginal people in Australia: national sentinel surveillance data. The Medical Journal of Australia 2017; 206(5): 205-209. doi:10.5694/mja16.00597
  2. Ampt FH, El Hayek C, Agius PA, Bowring AL, Bartnik N, Van Gemert C, Fairley CK, Chow EPF, Bradshaw CS, Stephens N, Lim MSC, Hellard ME. Anorectal swabs as a marker of male-to-male sexual exposure in STI surveillance systems. Epidemiology & Infection 2017; 145(12):2530-2535. doi:10.1017/S095026881700098X
  3. Ana-Sosa-Batiz F, Johnston APR, Hogarth PM, Wines BD, Barr I, Wheatley AK, Kent SJ. Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults. Vaccine 2017; 35: 6451–6458. doi: 10.1016/j.vaccine.2017.09.062
  4. Bilardi J, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Vodstrcil L, Bellhouse C, Fairley CK, Bradshaw CS. Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis. PLoS One 2017; 12(3):e0173637. doi:10.1371/journal.pone.0173637
  5. Boettiger D, Law M, Dore G, Guy R, Callander D, Donovan B, O'Connor C, Fairley CK,   Hellard M, Matthews G.  Hepatitis C testing and re-testing among people attending sexual health services in Australia, and Hepatitis C incidence among people with Human Immunodeficiency Virus: Analysis of national sentinel surveillance data.  BMC Infectious Diseases2017; 17:740. doi:10.1186/s12879-017-2848-0
  6. Callander D, Read P, Prestage G, Minichiello V, Chow EPF, Lewis DA, McNulty A, Ali H, Hellard M, Guy R, Donovan B. A cross-sectional study of HIV and STIs among male sex workers attending Australian sexual health clinics. Sexually Transmitted Infections 2017; 93(4): 299-302. doi: 10.1136/sextrans-2016-052578
  7. Callander D, McManus H, Guy R, Hellard M, O’Connor CC, Fairley CK, Chow EPF, McNulty A, Lewis DA, Carmody C, Schmidt HMA, Kim J, Donovan B. Rising chlamydia and gonorrhoea incidence and associated risk factors among female sex workers in Australia: a retrospective cohort study. Sexually Transmitted Diseases 2018; 45(3): 199-206. doi: 10.1097/OLQ.0000000000000714
  8. Chow EPF, Walker S, Read TRH, Chen MY, Bradshaw CS, Fairley CK. Self-reported use of mouthwash and pharyngeal gonorrhoea detection by nucleic acid amplification test. Sexually Transmitted Diseases 2017; 44(10):593-595. doi:10.1097/OLQ.0000000000000654
  9. Chow EPF, Machalek DA, Tabrizi SN, Danielewski JA, Fehler G, Bradshaw CS, Garland SM, Chen MY, Fairley CK. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study. Lancet Infectious Disease 2017; 17(1): 68-77. doi:10.1016/S1473-3099(16)30116-5
  10. Chow EPF, Cornelisse VJ, Read TRH, Lee D, Walker S, Hocking JS, Chen MY, Bradshaw CS, Fairley CK. Saliva use as a lubricant for anal sex is a risk factor for rectal gonorrhoea among men who have sex with men, a new public health message: a cross-sectional survey. Sexually Transmitted Infections 2017; 92(7): 532-536.doi:10.1136/sextrans-2015-052502
  11. Chow EPF, Walker S, Hocking JS, Bradshaw CS, Chen MY, Tabrizi SN, Howden BP, Law MG, Maddaford K, Read TRH, Lewis DA, Whiley DM, Zhang L, Grulich AE, Kaldor JM, Cornelisse VJ, Phillips S, Donovan B, McNulty AM, Templeton DJ, Roth N, Moore R, Fairley CK. A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol. BMC Infectious Diseases 2017; 17(1):456. doi:10.1186/s12879-017-2541-3
  12. Chow EPF, Callander D, Fairley CK, Zhan g L, Donovan B, Guy R, Lewis DA,  Hellard M, Read P. Ward A, Chen MY.  Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis. Clinical Infectious Diseases 2017; 65(3): 389-395 doi:10.1093/cid/cix326
  13. Chow EP, Walker S, Phillips T, Fairley CK. Willingness to change behaviours to reduce the risk of pharyngeal gonorrhoea transmission and acquisition in men who have sex with men: a cross-sectional survey. Sexually Transmitted Infection 2017; 93(7): 499-502. doi:10.1136/sextrans-2017-053148
  14. Chen M, Guy R. Increasing syphilis rates among men who have sex with men and screening to detect asymptomatic infection. Sexual Health 2017; 14(4): 301-3. doi:10.1071/SH17037
  15. Cornelisse V, Sherman C, Hocking JS, Williams H, Zhang L, Chen MY, Bradshaw CS, Bellhouse C, Fairley CK, Chow EPF. Concordance of chlamydia infections of the rectum and urethra in same-sex male partnerships: A cross-sectional analysis. BMC Infectious Diseases 2017; 17:22. doi:10.1186/s12879-016-2141-7
  16. Cornelisse VJ, Chow EPF, Huffam S, Fairley CK, Bissessor M,  De Petra V, Howden BP, Denham I, Bradshaw CS, Williamson D, Chen MY. Increased detection of pharyngeal and rectal gonorrhea in men who have sex with men after transition from culture to nucleic acid amplification testing. Sexually Transmitted Diseases 2017; 44(2): 114-117. doi:10.1097/OLQ.0000000000000553
  17. Cromer D, Pinkevych M, Rasmussen T, Lewin S, Kent SJ, Davenport MP.  Modelling of anti-latency treatment in HIV; What is the optimal duration of anti-retroviral-free HIV remission? Journal of Virology 2017: 91(24): e01395-1. doi:10.1128/JVI.01395-1
  18. Danielewsi J, Phillips S, Kong FYS, Smith KS, Hocking JS, Guy R, Fairley CK, Garland, SM, Tabrizi SN. A snapshot of Chlamydia trachomatis genetic diversity using multilocus sequence type analysis in an Australian metropolitan setting. European Journal of Clinical Microbiology & Infectious Diseases2017; 36(7):1297-1303. doi.10.1007/s10096-017-2935-6
  19. Drolet M, Laprise JF, Brotherton JKL, Donovan B, Fairley CK, Ali H, Benard E, Martin D, Brisson M. The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation. Journal of Infectious Diseases 2017; 216(10): 1205-1209. doi:10.1093/infdis/jix476
  20. Fairley CK, Hocking JS, Zhang L, Chow EPF. Frequent transmission of gonorrhoea in men who have sex with men; why it is common. Emerging Infectious Disease 2017; 23(1): 102-104. doi:10.3201/eid2301.161205
  21. Gause KT, Wheatley AK, Cui J, Yan Y, Kent SJ, Caruso F. Immunological principles guiding the rational design of particles for vaccine delivery. ACS Nano 2017; 11: 54-68. doi:10.1021/acsnano.6b07343
  22. Gilbert M, Salway T, Haag D, Fairley CK, Wong J, Grennan T, Uddin Z, Cuchner C, Wong T, Krajde M, Tyndall M, Shoveller J, Ogilvie G. Use of GetCheckedOnline, a comprehensive web-based  testing service for sexually transmitted and blood-borne infections. Journal of Medical Internet Research 2017; 19(3):e81. doi:10.2196/jmir.7097
  23. Glass JJ, Chen L, Alcantara S, Crampin EJ, Thurecht KJ, De Rose R, Kent SJ. Charge has a marked influence on hyperbranched polymer nanoparticle association in whole human blood. ACS Macro Letters 2017; 6: 586-592. doi:10.1021/acsmacrolett.7b00229
  24. Glass JJ, Li Y, De Rose R, Johnston A, Czuba E, Khor SY, Quinn J, Whittaker M, Davis T, Kent SJ. Thiol-Reactive Star Polymers display enhanced association with distinct human blood components. ACS Applied Materials & Interfaces 2017; 9: 12182-94. doi:10.1021/acsami.6b15942
  25. Huffam S, Chow EPF, Leeyaphan C, Fairley CK, Hocking JS, Phillips S, Tabrizi SN, Bellhouse C, Bradshaw CS, Fehler G,  Garland SM, Chen MY. Chlamydia infection between men and women: a cross sectional study of heterosexual partnerships. Open Forum Infectious Diseases2017;4(3): ofx160. doi:10.1093/ofid/ofx160
  26. Jamil M, Bavinton B, Fairley CK, Grulich AE, Holt M, Smith K, Chen MY, McNaulty A, Conway D, Keen P, Bradley J, Russell D, Kaldor J. HIV testing self-efficacy is associated with higher HIV testing frequency and perceived likelihood to self-test among gay and bisexual men. Sexual Health 2017; 14(2): 170-178.doi:10.1071/SH16100
  27. Jamil MS, Prestage G, Fairley CK, Grulich AE, Smith KS, Chen MY, Holt M, McNulty A, Bavington BR, Conway DP, Wand H, Keen P, Bradley J, Kolstee J, Batrouney C, Russell D, Law M, Kaldor JM, Guy RJ. Effect of availability of HIV self-testing on HIV testing frequency among gay and bisexual men at higher risk of infection: a wait-list randomised controlled trial (FORTH). Lancet HIV 2017; 6(4):e241-250. doi:10.1016/S2352-3018(17)30023-1
  28. Jasek E, Chow EPF, Ong JJ, Bradshaw CS, Chen MY, Hocking JS, Lee D, Phillips T, Temple-Smith M, Fehler G, Fairley CK. Sexually transmitted Infections in Melbourne, Australia from 1918 to 2016: nearly a century of data. Communicable Diseases Intelligence 2017; 41(3): E212-E222
  29. Jin F, Roberts JM, Poynten IM, Machalek DA, Cornall A, Phillips S, Ekman D, McDonald RL, Hillman RJ, Templeton DJ, Farnsworth A, Garland SM, Fairley CK, Tabrizi SN. The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men. AIDS 2017; 31(9): 1303-1311. doi:10.1097/QAD.0000000000001462
  30. Juno JA, van Bockel D, Kent SJ, Kelleher AD, Zaunders JJ, Munier CM. Cytotoxic CD4 T cells - friend or foe during viral infection? Frontiers in Immunology 2017; 8: Article 19. doi:10.3389/fimmu.2017.00019
  31. Kent SJ, Chung AW. A Role for Fc-mediated humoral immunity in reducing HIV transmission rates between HIV serodiscordant heterosexual couples. EBiomedicine 2017; 26: 2-3. doi:10.1016/j.ebiom.2017.11.011
  32. Kent SJ. HIV Vaccine Approaches. In: eLS. John Wiley & Sons, Ltd: Chichester. doi: 10.1002/9780470015902.a0021550.pub3
  33. Kong FYS, Rupasinghe TW, Simpson JA, Vodstrcil LA, Fairley CK, McConville MJ, Hocking JS. Pharmacokinetics of a single 1g dose of azithromycin in rectal tissue in men. PLoS One 2017;12(3):e0174372. doi:10.1371/journal.pone.0174372
  34. Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth M, Chung AW, Kent SJ, Held K, Geldmacher C, Dally L, Santos NS, Cole T, Gilmour J, Fidler S, Shattock RJ. A Phase I HIV vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime-boost vaccine regimens. Frontiers in Immunology 2017; 8: 595. doi:10.3389/fimmu.2017.00595
  35. Kulkarni A, Kurle S, Shete A, Ghate M, Godbole S, Madhavi V, Kent SJ, Paranjape R, Thakar M. Indian long-term non-progressors show broad ADCC responses with preferential recognition of V3 region of Envelope and a region of Tat protein. Frontiers in Immunology 2017; 8: 5. doi:10.3389/fimmu.2017.00005
  36. Lahra MM, Trembizki E, Buckley C, Donovan B, Chen M, Guy R, Kundu RL, Regan DG, Whiley DM. Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes. Journal of Antimicrobial Chemotherapy2017; 72(3): 705-11. doi:10.1093/jac/dkw452
  37. Lal L, Audsley J, Murphy D, Fairley CK, Stoove M, Roth N, Moore R, Tee BK, Puratmaja N, Anderson PL, Leslie D, Grant RM, De Wit J, Wright E. Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project. AIDS 2017; 31(12): 1709-1714. doi:10.1097/QAD.0000000000001519
  38. Lau, A, Kong, F, Fairley CK, Donovan B, Chen M, Bradshaw C, Boyd M, Amin J, Tabrizi S, Regan DG, Lewis DA, McNaulty A, Hocking JS. Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol. BMC Infectious Diseases 2017; 17(1): 35. doi:10.1186/s12879-016-2125-7
  39. Lee WS, Kristensen AB, Rasmussen TA, Tolstrup M, Østergaard L, Søgaard OS, Wines BD, Hogarth PM, Reynaldi A, Davenport M, Emery S, Amin J, Cooper DA, Kan V, Fox J, Grüll H, Parsons MS, Kent SJ. Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption. Journal of Virology 2017; 91: e00603. doi:10.1128/JVI.00603-17
  40. Leeyaphan C, Ong JJ, Chow EPF, Dimovski K, Kong FYS,  Hocking JS, Howden B, Bissessor M,  Fairley CK, Bradshaw CS, Read TRH, Chen MY. Treatment outcomes for rectal lymphogranuloma venereum in men who have sex with men using doxycycline, azithromycin or both: a review of clinical cases. Sexually Transmitted Diseases 2017; 44(4): 245-248. doi:10.1097/OLQ.0000000000000578
  41. Li B, Bi P, Ward A, Bell C, Fairley CK. Trends and predictors of recent HIV testing over 22 years among a clinic sample of men who have sex with men in South Australia. Sexual Health 2017; 14(2): 164-169. doi:10.1071/SH16091
  42. Li S, Su S, Li S, Gao L, Cai Y, Fu Y, Fu J, Guo C, Lu W, Cheng F, Jing J, Chen L, Zhang L. A comparison of effectiveness between oral rapid testing and routine serum-based testing for HIV in an outpatient dental clinic in Yuxi Prefecture, China: a case–control study. BMJ Open 2017; 7(6):e014601. doi:10.1136/bmjopen-2016-014601
  43. Lloyd SB, Niven KP, Kiefel BR, Montefiori DC, Reynaldi A, Davenport MP, Kent SJ, Winnall WR. Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV. Human Vaccines and Immunotherapeutics2017; 13(11): 2726-2737. doi:10.1080/21645515.2017.1368935
  44. Machalek DA, Chow EPF, Garland SM, Wigan R, Cornall AM, Fairley CK, Kaldor JM, Hocking JS, Williams H, McNulty A, Bell C, Marshall L, Ooi C, Chen MY, Tabrizi SN. Human papillomavirus prevalence in unvaccinated heterosexual males following a national female vaccination program. Journal of Infectious Diseases 2017; 215(2): 202-208. doi:10.1093/infdis/jiw530
  45. Madhavi V, Wines BD, Amin J, Emery S, ENCORE1 Study Group, Lopez E, Kelleher A, Sydney LTNP Study Group, Center RG, Hogarth PM, Chung AW, Kent SJ, Stratov I. HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV. Journal of Virology 2017: 91(18): 1-16. doi:10.1128/JVI.00700-17
  46. Madhavi V, Kulkarni A, Shete A, Lee WS, Mclean MR, Kristensen AB, Ghate M, Wines BD, Hogarth PM, Parsons MS, Kelleher AD, Cooper DA, Amin J, Emery S, Thakar M, Kent SJ. Effect of combination antiretroviral therapy on HIV-1-specific antibody-dependent cellular cytotoxicity responses in subtype B- and subtype C-infected cohorts. Journal of Acquired Immune Deficiency Syndromes 2017; 75: 345-353. doi:10.1097/QAI.0000000000001380
  47. McAllister J, Towns JM, McNulty A, Pierce AB, Foster R, Richardson R, Carr A. Dolutegravir with tenovir disoproxil fumarate – emtricitabine as HIV post-exposure prophylaxis in gay and bisexual men. AIDS 2017; 31(9):1291-1295. doi.10.1097/QAD.0000000000001447
  48. Mclean MR, Madhavi V, Wines BD, Hogarth PM, Chung A, Kent SJ. Dimeric Fcγ receptor ELISA to study HIV-specific antibodies: a new look into breadth of Fcγ receptor antibodies induced by the RV144 vaccine trial. The Journal of Immunology 2017; 199: 816-26
  49. Medland NA, Chow EPF, Bradshaw CS, Read THR, Sasadeusz JJ, Fairley CK. Predictors and incidence of sexually transmitted Hepatitis C virus infection in HIV positive men who have sex with men. BMC Infectious Diseases 2017; 17:185. doi:10.1186/s12879-017-2288-x
  50. Medland NA, Chow EPF, McMahon JH, Elliott JH, Hoy JF, Fairley CK. Time form HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015. PLoS One. 2017;12(5): e0177634.doi: 10.1371/journal.pone.0177634
  51. Medland NA, Nicholson S, Chow EPF, Read THR, Bradshaw CS, Denham I, Fairley CK. Time from HIV infection to virological suppression: dramatic fall from 2007 to 2016. AIDS 2017; 31(17): 2377-2385. doi: 10.1097/QAD.0000000000001634
  52. Murray GL, Bradshaw CS, Bissessor M, Danielewski J, Garland SM, Jensen J, Fairley CK, Tabrizi SN. Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium. Emerging Infectious Diseases 2017; 23(5): 809-812. doi:10.3201/eid2305.161745
  53. Ong D, Bhardwaj G, Ong J, Chen M, Lim LL. Keeping an eye on syphilis. Australian Family Physician 2017; 46(6): 401-4
  54. Ong JJ, Morton AN, Henzell HR, Berzins K, Druce, J, Fairley CK, Bradshaw CS, Read TRH, Hocking JS, Chen MY. Clinical characteristics of herpes simplex virus urethritis compared with chlamydial urethritis Among Men. Sexually Transmitted Diseases 2017; 44(2): 121-125. doi:10.1097/OLQ.0000000000000547
  55. Ong JJ, Sarumpaet A, Chow EPF, Bradshaw CS, Chen MY, Read TRH, Fairley CK. Should female partners of men with non-gonococcal urethritis, negative for Chlamydia trachomatis and Mycoplasma genitalium, be informed and treated? Clinical outcomes from a partner study of heterosexual men with NGU. Sexually Transmitted Diseases 2017; 44(2): 126-130. doi:10.1097/OLQ.0000000000000546
  56. Ong JJ, Towns J, Chen MY, Fairley CK. Occult syphilitic chancres in the rectum and oropharynx. Australian Family Physician 2017; 46(9): 673-675
  57. Ong JJ, Fethers K, Howden BP, Fairley CK, Chow EPF, Williamson DA, Petalotis I, Aung E, Kanhutu K, De Petra V, Chen MY. Asymptomatic and symptomatic urethral gonorrhoea in men who have sex with men attending a sexual health service. Clinical Microbiology and Infection 2017; 23(8): 555-559. doi.10.1016/j.cmi.2017.02.020
  58. Ong JJ, Henzell H, Doyle L, Fairley CK. The intrauterine contraceptive device is where? An unexpected cause of intravesical IUCD. Australian Family Physician 2017;46(7):479-480
  59. Ong JJ, Peng M, Zhu S, Lo YRJ, Fairley CK, Kidd MR, Roland M, Jiang S, Wong WCW. Opportunities and barriers to STI testing in community health centres in China: a nationwide survey. Sexually Transmitted Infections 2017; 93(8): 566-571. doi:10.1136/sextrans- 2017- 053196
  60. Ong JJ, Chow EPF, De Petra V, Williamson D, Petalotis I, Howden B, Zhang L, Chen MY, Bradshaw CS, Hocking JS, Fairley CK. Should asymptomatic men who have sex men be screened for oropharyngeal chlamydia? Clinical outcomes from a cross-sectional study. Sexually Transmitted Diseases 2018; 45(2): 103-106
    doi: 10.1097/OLQ.0000000000000718
  61. Parsons MS, Lloyd SB, Lee WS, Kristensen AB, Amarasena T, Center RJ, Keele BF, Lifson JD, LaBranche CC, Montefiori D, Wines BD, Hogarth PM, Swiderek KM, Venturi V, Davenport MP, Kent SJ. Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection. Science Translational Medicine2017; 09 Aug; 9(402): eaaf1483 doi:10.1126/scitranslmed.aaf1483
  62. Petravic J, Rasmussen TA, Lewin SR, Kent SJ, Davenport MP. Relationship between measures of HIV reactivation and the decline of latent reservoir under latency-reversing agents. Journal of Virology 2017; 91: e02092-16
  63. Plummer EL, Garland SM, Bradshaw CS, Law MG, Vodstrcil LA, Hocking JS, Fairley CK, Tabrizi SN. Molecular diagnosis of bacterial vaginosis: does adjustment for total bacterial load or human cellular content improve diagnostic performance? Journal of Microbiological Methods 2017; 133: 66-68. doi:10.1016/j.mimet.2016.12.024
  64. Poynten M, Tabrizi SN, Jin F, Templeton DJ, Machalek DA, Cornall A, Phillips S, Fairley CK, Garland SM, Law C, Carr A, Hillman RJ, Grulich AE. Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men. Papillomavirus Research 2017; 3: 80-84. doi:10.1016/j.pvr.2017.02.003
  65. Priest D, Ong JJ, Chow EPF, Tabrizi S, Phillips S, Bissessor M, Fairley CK, Bradshaw CS, Read TRH, Garland SM, Chen MY. Neisseria gonorrhoeae DNA bacterial load in men with symptomatic and asymptomatic gonococcal urethritis. Sexually Transmitted Infections 2017; 93(7): 478-481. doi: 10.1136/sextrans-2016-052950
  66. Purnomo J, Coote K, Mao L, Fan L, Gold J, Ahmad R, Zhang L. Using eHealth to engage and retain priority populations in the HIV treatment and care cascade in the Asia-Pacific region: a systematic review of literature. BMC Infectious Diseases 2018; 18(1): 82
  67. Rasmussen TA, McMahon J, Chang JJ, Symons J, Roche M, Dantanarayana A, Okoye A, Hiener B, Palmer S, Lee WS, Kent SJ, Van Der Weyden C, Prince HM, Cameron PU, Lewin SR. Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome. AIDS 2017; 31: 1839-45. doi:10.1097/QAD.0000000000001540
  68. Read TRH, Fairley CK, Tabrizi SN, Bissessor M, Vodstrcil L, Chow EPF, Grant M, Danielewski J, Garland SM, Hocking JS, Chen MY, Bradshaw CS. Azithromycin 1.5g over five days compared to 1g single dose in urethral Mycoplasma genitalium: impact on treatment outcome and resistance. Clinical Infectious Diseases 2017; 64(3): 250-256. doi:10.1093/cid/ciw719
  69. Rockman S, Lowther S, Camuglia S, Vandenberg K, Taylor S, Fabri L, Miescher S, Pearse M, Middleton D, Kent SJ, Maher D. Intravenous immunoglobulin protects against severe pandemic influenza infection. EBioMedicine2017; 19: 119-27
  70. Selva KJ, Kent SJ, Parsons MS. Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma. AIDS 2017; 31: 333-42. doi:10.1097/QAD.0000000000001319
  71. Slifirski JB, Vodstrcil LA, Fairley CK, Ong JJ, Chow EPF, Chen MY, Read TRH, Bradshaw CS. Mycoplasma genitalium infection in males and females reporting sexual contact with infected partners. Emerging Infectious Diseases 2017; 23(11): 1826-1833. doi.10.3201/eid2311.170998
  72. Smith KS, Guy R, Danielewski J, Tabrizi SN, Fairley CK, McNulty AM, Rawlinson W, Saville M, Garland SM, Donovan B, Kaldor JM, Hocking JS. Biological and behavioural factors associated with positive chlamydia retests. Sexually Transmitted Diseases 2017; 44(7): 417- 422. doi:10.1097/OLQ.0000000000000616
  73. Song D, Cui J, Sun H, Nguyen TH, Alcantara S, De Rose R, Kent SJ, Porter CJH, Caruso F. Templated polymer replica nanoparticles to facilitate assessment of material-dependent pharmacokinetics and biodistribution. ACS Applied Materials and Interfaces. 2017; 9: 33683-33694
  74. Su JP, Tan LY, Garland SM, Tabrizi SN, Mokany E, Walker S, Bradshaw CS, Read T, Murray GL. Evaluation of the SpeeDx ResistancePlus MG Diagnostic Test for Mycoplasma genitalium on the Applied Biosystems 7500 Fast Quantitative PCR Platform. Journal of Clinical Microbiology 2017; 56(1) pii: e01245-17. doi:10.1128/JCM.01245-17
  75. Tabrizi SN, Su J, Bradshaw CS, Fairley CK, Walker S,  Tan LY, Mokany E,  Garland SM. Prospective evaluation of ResistancePlus™ MG, a new multiplex qPCR assay for the detection of Mycoplasma genitalium and macrolide resistance. Journal of Clinical Microbiology 2017; 55(6): 1915-1919.doi:10.1128/JCM.02312-16
  76. Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Research in Microbiology2017; 168(9-10): 782-792. doi:10.1016/j.resmic.2017.04.001
  77. Tan HX, Wheatley AK, Glass JJ, Masopust D, De Rose R, Kent SJ. Induction of vaginal resident HIV-specific CD8 T-cells with mucosal prime-boost immunisation. Mucosal Immunology 2017; doi:10.1038/mi.2017.89
  78. Templeton DJ, Roberts JM, Poynten IM, Law C, Hillman RJ, Farnsworth A, Fairley CK, Tabrizi SN, Garland SM, Grulich AE, Jin F. Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: baseline findings from the Study of the Prevention of Anal Cancer (SPANC). European Journal of Cancer Prevention 2017; 26(3): 212-216. doi:10.1097/CEJ.0000000000000321
  79. Tomnay JE, Hulme-Chambers A, Bilardi JE, Fairley CK, Huffam S, Chen MY. A qualitative study of means to improve partner notification following an HIV diagnosis among men who have sex with men in Australia. AIDS Patient Care and STDs 2017;31(6):269-274. doi:10.1089/apc.2017.0080
  80. Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, Marrazzo JM, Sonder GJB, Schwebke JR, Hoornenborg E,  Peeling RW, Philip SS, Low N, Fairley CK. Sexually transmitted infections: challenges ahead.Online Only The Lancet Infectious Diseases 2017; 17(8): e235–e279. doi:10.1016/S1473-3099(17)30310-9
  81. Vanderven HA, Jegaskanda S, Wines BD, Hogarth PM, Carmuglia S, Rockman S, Chung AW, Kent SJ. Antibody dependent cellular cytotoxicity immune responses to seasonal influenza vaccination in the elderly. Journal of Infectious Diseases 2017; 217: 12-23
  82. Vanderven HA, Liu L, Ana-Sosa-Batiz F, Nguyen TH, Wan Y, Wines B, Hogarth PM, Tilmanis D, Reynaldi A, Parsons MS, Hurt AC, Davenport MP, Kotsimbos T, Cheng AC, Kedzierska K, Zhang X, Xu J, Kent SJ. Fc functional antibodies during severe human H7N9 and seasonal influenza. JCI Insight 2017; 2: e92750. doi:10.1172/jci.insight.92750
  83. Vodstrcil LA,  Rupasinghe TWT, Kong KYS, Tull D, Worthington K, Chen MY, Huston WM, Timms P, McConville MJ, Fairley CK, Bradshaw CS, Tabrizi SN, Hocking JS. Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS). PLoS One 2017; 12(5): e0177615.doi;10.1371/journal.pone.0177615
  84. Vodstrcil LA, Twin J, Garland SM, Fairley CK, Hocking JS, Law MG, Plummer EL, Fethers KA, Chow EPF, Tabrizi SN, Bradshaw CS. The influence of sexual activity on the vagina microbiota and Gardnerella vaginalis clade diversity in young women. PLoS ONE 2017; 12(2): e0171856. doi:10.1371/journal.pone.0171856
  85. Wentzensen N, Arbyn M, Berkhof H, Bower M, Canfell K, Einstein M, Fairley CK, Monsonego J. Franceschi S. Eurogin 2016 Roadmap: How HPV knowledge is changing screening practice. International Journal of Cancer2017; 140(10):2192-2200. doi:10.1002/ijc.30579
  86. Whiley DM, Trebizki E, Buckle C, Freeman K, Baird RW, Beaman M, Chen MY, Donovan B, Kundu RL, Fairley CK, Guy R, Hogan T, Kaldor JM, Karimi M, Limnios A, Regan DG, Ryder N, Su JY, Ward J, Lahra MM. Molecular antimicrobial resistance surveillance for Neisseria gonorrhoeae in practice. Emerging Infectious Diseases 2017; 23(9):1478-1485. doi: 10.3201/eid2309.170427
  87. Wilkinson AL, El-Hayek CE, Fairley CK, Roth N, Tee BK, McBryde E, Hellard M, Stoové M. Measuring transitions in sexual risk among men who have sex with men: The novel use of latent class and latent transition analysis in HIV sentinel surveillance. American Journal of Epidemiology 2017. 185(8): 627-635. doi:10.1093/aje/kww239
  88. Wilkinson AL, McNamee K, El-Hayek C, Chow EPF, Bradshaw CS, Roth N, Tee BK, Stoové M, Hellard M. Utility of risk-based chlamydia testing in primary care: analysis of retrospective surveillance data among women in Melbourne, Australia. Sexual Health 2017; 14(3): 268-273. doi:10.1071/SH16202
  89. Xu X, Zuo H, Shi Z, Rao Y, Wang L, Zeng H, Zhang L, Sharma M, Reis C, and Zhao Y. Determinants of second pregnancy among pregnant women: a hospital-based cross-sectional survey in China. BMJ Open2017; 7 7:e014544. doi:10.1136/bmjopen-2016-014544
  90. Xu Y, Phetsouphanh C, Suzuki K, Aggarwal A, Graff-Dubois S, Roche M, Bailey M, Alcantara S, Flanagan S, Cash K, Siva R, Koelsch KK, Autran B, Harvey R, Gorry PR, Moris A, Cooper DA, Turville S, Kent SJ, Kelleher AD, Zaunders J. HIV-1 and SIV predominantly use CCR5 expressed on a precursor population to establish infection in T follicular helper cells. Frontiers in Immunology 2017; 8:
  91. Yang H, Xiao L, Zhang L, S. Deepal, Ye G and Zhang X. "Epidemic trend of periodontal disease in elderly Chinese population, 1987–2015: a systematic review and meta-analysis." Scientific Reports2017; 7: 45000. doi:10.1038/srep45000
  92. Yap L, Shu S, Zhang L, et al. Psychological distress among re-education through labour camp detainees in Guangxi Autonomous Region, China. Journal of Mental Health2017; 26(1): 57-65. doi:10.1080/09638237.2016.1276529
  93. Zaunders J, Xu Y, Kent SJ, Koelsch KK, Kelleher AD. Divergent expression of CXCR5 and CCR5 on CD4+ T cells and the paradoxical accumulation of T follicular helper cells during HIV infection. Frontiers in Immunology2017; 8: Article 495
  94. Zhang L, Regan DG, Gambhir M, Cornelisse V, Grulich AG, Ong JJ, Lewis DA, Hocking J, Fairley CK. Neisseria gonorrhoeae transmission among men who have sex with men: an anatomical site-specific mathematical model evaluating the potential preventive impact of mouthwash. Sexually Transmitted Disease 2017;44(10):586-592. doi:10.1097/OLQ.0000000000000661
  95. Zhang L, Regan DG, Ong JJ, Gambhir M, Chow EPF, Zou H, Matthew L, Hocking J, Fairley CK. Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective. Vaccine 2017;35(37):4923-4929. doi:10.1016/j.vaccine.2017.07.078